Should I Buy CDLX? CDLX 2026 Analysis

Should You Buy Cardlytics Inc (CDLX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.020

1 Day change

-0.97%

52 Week Range

3.620

Analysis Updated At

2026/01/28

CDLX is not a good buy right now for a Beginner long-term investor with $50k–$100k who wants an immediate, straightforward entry. The stock is in a steep downtrend near ~$1, fundamentals are deteriorating (Q3 2025 revenue -22% YoY with deeper losses), and volatility is extremely high. The Bridg asset sale is a positive cash/catalyst event, but it does not outweigh the current weak growth and bearish technical trend for a long-term “buy-and-hold” profile.

Technical Analysis

Price/Trend: CDLX is bearish (SMA_200 > SMA_20 > SMA_5), signaling a persistent downtrend. Momentum: MACD histogram is negative (-0.0202) and expanding lower, confirming downside momentum is still building. RSI(6) is ~24, which is oversold (near-term bounce risk exists), but oversold can persist in strong downtrends. Levels: Pivot 1.16; key support S1 ~1.036 (very close to current 1.045) then S2 ~0.959; resistance R1 ~1.284 then R2 ~1.361. With today’s -7.21% drop and price sitting on/near support, this is technically fragile—one more push lower can break support. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/Positioning: Put-call ratios are very low (OI PCR 0.22; Volume PCR 0.17), which is call-heavy and typically bullish/“risk-on” positioning. Activity/Volatility: Implied vol is extremely elevated (IV30 ~242%, IV percentile 96.4) and much higher than historical volatility (~126%), implying the options market is pricing in outsized moves and event risk. Takeaway: Options flow looks optimistic, but the very high IV also indicates the market expects instability; this is more consistent with speculative trading than a clean long-term entry.

Technical Summary

Sell

Buy

Positive Catalysts

Event-driven catalyst: PAR Technology agreed to acquire Cardlytics’ Bridg platform for $27.5M (up to $30M), expected to close in Q1 2026—could improve liquidity and narrow strategic focus.
Trading trends: Hedge funds are reported as buying aggressively (+361.26% QoQ in buying amount), which can support near-term sentiment.

Neutral/Negative Catalysts

Strong bearish technical trend with accelerating negative MACD and price near critical support around ~$1.
Extremely high volatility/uncertainty (options IV percentile 96.4), which is unfavorable for a beginner long-term profile seeking stability.
Business performance deterioration (revenue down sharply YoY; losses widening), which undermines long-term compounding.

Financial Performance

Latest quarter provided: 2025/Q3. Revenue fell to $52.03M (-22.41% YoY). Net income was -$72.67M (loss worsened, -49.94% YoY). EPS was -1.36 (-53.10% YoY). Gross margin improved to 45.27% (+3.21% YoY), which is a positive efficiency signal, but it is not translating into profitability—overall growth and earnings trends are negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating changes or price target updates were provided in the data, so a true trend summary cannot be confirmed. Based on the supplied fundamentals (declining revenue, larger losses) and penny-stock pricing, the typical Wall Street debate here would be: Pros—asset sale/cash infusion and potential turnaround optionality; Cons—weak growth, ongoing heavy losses, and high volatility. Net view from the provided data skews negative for long-term beginners.

4 Analyst Rating

Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is 1.63 USD with a low forecast of 1.5 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

3 Hold

1 Sell

Hold

Current: 1.030

Low

1.5

Averages

1.63

High

Current: 1.030

Low

1.5

Averages

1.63

High

Lake Street

Hold

downgrade

AI Analysis

2025-05-08

Reason

Lake Street

Price Target

AI Analysis

2025-05-08

downgrade

Hold

Reason

Lake Street lowered the firm's price target on Cardlytics to $2.50 from $3 and keeps a Hold rating on the shares. Cardlytics' solid Q1 and in line guidance is "encouraging," but the firm expects billings comps to be a headwind to growth the next two quarters, the analyst tells investors. Cardlytics "remains in the proving grounds, but there are encouraging signals Cardlytics could see a return to growth," added the analyst, who cites multiple compression in the space for the firm's lowered target.

Needham

Kyle Peterson

Hold

Reiterates

n/a

2025-03-13

Reason

Needham

Kyle Peterson

Price Target

n/a

2025-03-13

Reiterates

Hold

Reason

CDLX Should I Buy

CDLX Should I Buy

Should You Buy Cardlytics Inc (CDLX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch